gabapentin
FDA Approved, EMA Approved
Description
Gabapentin is an anticonvulsant and neuropathic pain medication that modulates voltage-gated calcium channels. It is used off-label for symptomatic management of neuropathic pain and ataxia in various hereditary neurological disorders. The drug has a favorable safety profile and is widely available for supportive care in rare neurological conditions.
Indications & Therapeutic Use
Neuropathic pain, partial seizures, ataxia management, peripheral neuropathy
Linked Diseases:
myofibrillar myopathy 6
C567843
Global Availability (11 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
gabapentin
| Generic Name | gabapentin |
| Brands | 1 brand available |
| Active Ingredient | gabapentin |
| Drug Class | Neuropathic pain |
| Manufacturer | Pfizer |
| Dosage Forms | Oral capsule 100mg, 300mg, 400mg; Oral tablet 600mg, 800mg; Oral solution 250mg/5mL |
| Medical Code | N03AX12 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT00001854 |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes